首页> 美国卫生研究院文献>Springer Open Choice >Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta accelerates vimentin degradation and suppresses epithelial–mesenchymal transition in non-small cell lung cancer cells
【2h】

Cytoplasmic aryl hydrocarbon receptor regulates glycogen synthase kinase 3 beta accelerates vimentin degradation and suppresses epithelial–mesenchymal transition in non-small cell lung cancer cells

机译:细胞质芳烃受体调节糖原合酶激酶3β促进波形蛋白降解并抑制非小细胞肺癌细胞的上皮-间质转化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aryl hydrocarbon receptor (AHR), a ligand-activated transcription factor, has been studied extensively in carcinogenesis through the genomic pathway. In recent years, AHR has also been reported to exert positive or negative effects on epithelial–mesenchymal transition (EMT), the crucial step in tumor malignant progression. However, the detailed mechanism remains controversial. Analysis of AHR-expression levels in non-small cell lung cancer cell lines and lung cancer tissues revealed an inverse correlation between AHR protein levels and tumor cell invasion and metastasis. Overexpression of wild-type AHR in H1299 cells (AHR poorly expressed, potently invasive) not only accelerated mesenchymal vimentin degradation, but also prevented cell invasion in vitro and in vivo. In the absence of AHR agonists, the overexpressed AHR protein was predominantly localized in the cytoplasm, where it interacted with vimentin and functioned as an E3 ubiquitin ligase. A 6-h incubation with the proteasome inhibitor MG-132 fully rescued vimentin from AHR-mediated proteasomal degradation. In AHR-overexpressing H1299 cells, either vimentin degradation or invasive suppression could be reversed when glycogen synthase kinase 3 beta (GSK3β) was inactivated by CHIR-99021 treatment. In contrast, silencing of AHR in A549 cells (AHR highly expressed, weakly invasive) resulted in the downregulation of epithelial biomarkers (E-cadherin and claudin-1), augmentation of mesenchymal vimentin level, and GSK3β Ser-9 hyper-phosphorylation, which led to enhanced invasiveness. This work demonstrates that cytoplasmic, resting AHR protein may act as an EMT suppressor via a non-genomic pathway. Depletion of cytoplasmic AHR content represents a potential switch for EMT, thereby leading to the scattering of tumor cells.Electronic supplementary materialThe online version of this article (doi:10.1007/s00204-016-1870-0) contains supplementary material, which is available to authorized users.
机译:芳烃受体(AHR),一种配体激活的转录因子,已通过基因组途径在致癌作用中进行了广泛研究。近年来,还报道了AHR对上皮间质转化(EMT)产生正向或负向影响,这是肿瘤恶性进展的关键步骤。但是,详细机制仍存在争议。对非小细胞肺癌细胞系和肺癌组织中AHR表达水平的分析揭示了AHR蛋白水平与肿瘤细胞浸润和转移之间的负相关。 H1299细胞中野生型AHR的过表达(AHR表达低下,强力侵袭)不仅加速了间质波形蛋白的降解,而且在体内外均阻止了细胞的侵袭。在没有AHR激动剂的情况下,过表达的AHR蛋白主要位于细胞质中,在这里它与波形蛋白相互作用,并起E3泛素连接酶的作用。与蛋白酶体抑制剂MG-132孵育6小时,可将波形蛋白完全从AHR介导的蛋白酶体降解中拯救出来。在过表达AHR的H1299细胞中,当糖原合酶激酶3 beta(GSK3β)通过CHIR-99021处理失活时,波形蛋白降解或侵袭性抑制均可逆转。相比之下,A549细胞中AHR的沉默(AHR高表达,微创)导致上皮生物标志物(E-cadherin和claudin-1)下调,间质波形蛋白水平升高以及GSK3βSer-9过度磷酸化。导致增强的侵袭性。这项工作表明,细胞质的静止AHR蛋白可以通过非基因组途径充当EMT抑制剂。细胞质AHR含量的减少代表着EMT的潜在转换,从而导致肿瘤细胞的散布。电子补充材料本文的在线版本(doi:10.1007 / s00204-016-1870-0)包含补充材料,可用于授权用户。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号